Why it was recalled
CGMP Deviations: product found to contain lead.
Product description
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Lot numbers, UPCs & expiration codes
Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Where it was sold
Product was distributed to one customer in NY.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0332-2026
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- Dec 22, 2025
- FDA report date
- Feb 11, 2026
- Quantity
- 4 bottles /30 capsules each
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- HANDELNINE GLOBAL LLC
Original FDA data
Every field from FDA enforcement report D-0332-2026, exactly as published.
Show all FDA fields
- City
- South Plainfield
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98165
- Address
- South Plainfield
- Address (line 2)
- 4300 S Clinton Ave
- Code information
- Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
- Postal code
- 07080-1219
- Report date
- Feb 11, 2026
- Product type
- Drugs
- Recall number
- D-0332-2026
- Classification
- Class I
- Recalling firm
- HANDELNINE GLOBAL LLC
- Product quantity
- 4 bottles /30 capsules each
- Reason for recall
- CGMP Deviations: product found to contain lead.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
- Distribution pattern
- Product was distributed to one customer in NY.
- Recall initiation date
- Dec 22, 2025
- Initial firm notification
- Press Release
- Center classification date
- Feb 12, 2026